Baird Upgrades Amedisys (AMED) to Neutral
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $91.05 -0.12%
Rating Summary:
8 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
8 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Baird upgraded Amedisys (NASDAQ: AMED) from Underperform to Neutral with a price target of $25.00.
For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.
Shares of Amedisys closed at $21.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Outperform
- Mizuho Upgrades Airbnb Inc. (ABNB) to Buy, 'We see opportunities'
- BofA Securities Upgrades Tesla (TSLA) to Buy on wind up of positive catalysts
Create E-mail Alert Related Categories
UpgradesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
